Skip to main content
36009 search results for:

Hepatitis E 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 21-02-2024 | Hepatitis B | ReviewPaper

    Hepatitis B Virus Elimination Strategies

    Globally, hepatitis B virus (HBV) is a major health problem, with an estimated 257.5 million people infected (3.23% of the population in 2022) and 820,000 deaths in 2019 [ 1 •, 2 ]. Progress in global vaccine distribution and improved antiviral …

  2. 08-03-2024 | Autoimmune Hepatitis | Online First

    A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis

    Non-A-E hepatitis (NAEH) is a well-recognized cause for acute liver failure (ALF). It is also known as indeterminate, cryptogenic, seronegative, non-A non-B, non-A non-B non-C and non-A non-E hepatitis [ 1 ]. It is a common indication for liver …

  3. Open Access 01-12-2024 | Hepatitis B | OriginalPaper

    Hepatitis B virus infection among illegal drug users in Enugu State, Nigeria: prevalence, immune status, and related risk factors

    Hepatitis B virus infection is a global health challenge that jeopardizes public health and security. An estimated 296 million people worldwide are living with chronic HBV infection, and each year 1.5 million new infections and 1.2 million …

  4. 01-07-2024 | Vulgar Psoriasis | Letter

    Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study

  5. 23-04-2024 | Autoimmune Hepatitis | Online First

    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study

    Autoimmune hepatitis (AIH) is a necroinflammatory liver disease that occurs in patients of all ages [ 1 ]. AIH is a prototypical autoimmune disease with a female predominance. The etiology of AIH remains mostly unresolved but likely results from …

  6. 13-05-2024 | Hepatitis C | Online First

    MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents

    Direct-acting antiviral agents (DAAs) have changed the treatment of hepatitis C virus (HCV) infection dramatically [ 1 , 2 ]. The achievement of a sustained virological response (SVR) by DAAs therapy usually results in regression of liver fibrosis …

  7. 01-05-2024 | Hepatitis C | BriefCommunication

    Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes

    Previously, we reported a neutralizing monoclonal antibody, A8A11, raised against a novel conserved epitope within the hepatitis C virus (HCV) E2 protein, that could significantly reduce HCV replication. Here, we report the nucleotide sequence of …

  8. Open Access 01-12-2024 | Hepatitis C | OriginalPaper

    Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets

    Viral hepatitis C (HCV) infections are a significant global public health challenge, affecting approximately 1% of the world’s population [ 1 ]. Currently, there is no vaccine to prevent the transmission of HCV. An estimated 5 million Europeans are …

  9. Open Access 10-02-2024 | Hepatitis B | ReviewPaper

    Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B

    Despite the availability of a safe and effective vaccine for over four decades, the global health burden of hepatitis B virus (HBV) infection remains high. Recent estimates suggest there are ~ 300 million people with chronic infection resulting in …

  10. Open Access 01-12-2024 | Hepatitis B | OriginalPaper

    Survey of lived experiences and challenges in hepatitis B management and treatment

    Almost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015 the World Health Organization (WHO) developed guidelines for the prevention, care, and treatment of …

  11. Open Access 01-12-2024 | Entecavir | OriginalPaper

    Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

    Because the covalently closed circular DNA of HBV serves as a template for viral replication, patients with both cancer and HBV are at risk of HBV reactivation (HBVr) when they undergo cytotoxic or immunosuppressive therapy, and this risk is …

  12. Open Access 01-12-2024 | Hepatitis C | OriginalPaper

    Patients’ experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation

    Globally, approximately 56.8 million people are living with hepatitis C and over three-quarters of those reside in low and middle-income countries (LMICs) [ 1 ]. Since the introduction of direct-acting antiviral (DAA) treatments for hepatitis C …

  13. 13-04-2024 | Autoimmune Hepatitis | Online First

    Succinic Acid Ameliorates Concanavalin A-Induced Hepatitis by Altering the Inflammatory Microenvironment and Expression of BCL-2 Family Proteins

    Autoimmune hepatitis (AIH) is a severe immune-mediated inflammatory liver disease that currently lacks feasible drug treatment methods. Our study aimed to evaluate the protective effect of succinic acid against AIH and provide a reliable method …

  14. Open Access 01-12-2024 | Hepatitis E | OriginalPaper

    Collateral effects of COVID-19 countermeasures on hepatitis E incidence pattern: a case study of china based on time series models

    Hepatitis E is a major public health problem and one of the most frequent causes of acute hepatitis worldwide. The global burden of hepatitis E is high; every year, there are approximately 20 million hepatitis E virus (HEV) infections, leading to …

  15. Open Access 01-12-2024 | Hepatitis | OriginalPaper

    Viscoelastic parameters derived from multifrequency MR elastography for depicting hepatic fibrosis and inflammation in chronic viral hepatitis

    Chronic liver diseases caused by viral hepatitis infections represent a significant global health concern [ 1 , 2 ]. Fibrosis, a well-documented consequence of these diseases, is a dynamic process that can be reversed with appropriate treatment …

  16. Open Access 05-04-2024 | Hepatitis A | Online First

    Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines

    Hepatitis A is an infectious disease caused by the hepatitis A virus (HAV), which is an RNA virus belonging to the picornavirus family, and infects primarily humans as its only natural host [ 1 ]. HAV is transmitted primarily by the fecal-oral …

  17. Open Access 01-12-2024 | Pregnancy Cholestasis | OriginalPaper

    The effect of intrahepatic cholestasis in pregnancy combined with different stages of hepatitis B virus infection on pregnancy outcomes: a retrospective study

    Intrahepatic cholestasis during pregnancy (ICP) is a common complication of pregnancy, characterized by elevated bile acid levels, skin pruritus, and elevated transaminase levels in the second half of pregnancy. ICP can lead to complications such …

  18. Open Access 01-12-2024 | Hepatitis C | OriginalPaper

    Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015–2021

    This comprehensive retrospective data-linkage study aimed at evaluating the impact of Direct-Acting Antivirals (DAAs) on Hepatitis C Virus (HCV) testing, treatment trends, and access to care in Tuscany over six years following their introduction.

  19. 20-02-2024 | Hepatitis B | OriginalPaper

    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B

    Chronic hepatitis B (CHB) is a persistent liver infection with the hepatitis B virus (HBV) that affects approximately 250 million people globally [ 1 ]. CHB-related morbidity and mortality are due to the development of liver failure from cirrhosis …

  20. Open Access 10-04-2024 | Hepatitis C | Online First

    Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.